Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2José L. Casado, Alejandro Vallejo, Beatriz Romero‐Hernández et al.|Vaccine X|2022Cited by 18
T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunityJosé L. Casado, Alejandro Vallejo, Johannes Häemmerle et al.|Clinical & Translational Immunology|2021Cited by 16
SARS-CoV-2 antibodies and utility of point of care testing in Health Care Workers from a spanish University Hospital in MadridMario Rodríguez-Domínguez, Rafael Cantón, Montserrat Ferré-Masferrer et al.|Clinical Microbiology and Infection|2021Cited by 3
Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 VaccinationJosé L. Casado, Marina Fernández-Escribano, Johannes Häemmerle et al.|Journal of Clinical Medicine|2022Cited by 3